DOI QR코드

DOI QR Code

Acute-onset chronic inflammatory demyelinating polyneuropathy following hepatitis A virus infection

  • Jung, Eui Sung (Department of Neurology, Nowon Eulji Medical Center, Eulji University School of Medicine) ;
  • Kim, Ye Sel (Department of Neurology, Samsung Medical center, School of Medicine, Sungkyunkwan University) ;
  • Min, Ju-Hong (Department of Neurology, Samsung Medical center, School of Medicine, Sungkyunkwan University) ;
  • Kang, Kyusik (Department of Neurology, Nowon Eulji Medical Center, Eulji University School of Medicine) ;
  • Lee, Jung Ju (Department of Neurology, Nowon Eulji Medical Center, Eulji University School of Medicine) ;
  • Park, Jong-Moo (Department of Neurology, Nowon Eulji Medical Center, Eulji University School of Medicine) ;
  • Kim, Byung-Kun (Department of Neurology, Nowon Eulji Medical Center, Eulji University School of Medicine) ;
  • Kwon, Ohyun (Department of Neurology, Nowon Eulji Medical Center, Eulji University School of Medicine)
  • Received : 2016.03.25
  • Accepted : 2016.07.19
  • Published : 2017.01.31

Abstract

An infection is less likely to elicit chronic inflammatory demyelinating polyneuropathy (CIDP) than Guillain-$Barr{\acute{e}}$ syndrome. We here report a case of acute-onset CIDP following hepatitis A virus infection and briefly comment on the potential mechanisms regarding the induction and chronicity of autoimmunity after a viral infection.

Keywords

References

  1. Israeli E, Agmon-Levin N, Blank M, Chapman J, Shoenfeld Y. Guillain-Barre syndrome--a classical autoimmune disease triggered by infection or vaccination. Clin Rev Allergy Immunol 2012;42:121-130. https://doi.org/10.1007/s12016-010-8213-3
  2. Melendez-Vasquez C, Redford J, Choudhary PP, Gray IA, Maitland P, Gregson NA, et al. Immunological investigation of chronic inflammatory demyelinating polyradiculoneuropathy. J Neuroimmunol 1997;73:124-134. https://doi.org/10.1016/S0165-5728(96)00189-0
  3. Horwitz MS, Sarvetnick N. Viruses, host responses, and autoimmunity. Immunol Rev 1999;169:241-253. https://doi.org/10.1111/j.1600-065X.1999.tb01319.x
  4. Manz RA, Moser K, Burmester GR, Radbruch A, Hiepe F. Immunological memory stabilizing autoreactivity. Curr Top Microbiol Immunol 2006;305:241-257.
  5. Van den Bergh PY, Hadden RD, Bouche P, Cornblath DR, Hahn A, Illa I, et al. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society - first revision. Eur J Neurol 2010;17:356-363. https://doi.org/10.1111/j.1468-1331.2009.02930.x
  6. Ruts L, Drenthen J, Jacobs BC, van Doorn PA; Dutch GBS Study Group. Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study. Neurology 2010;74:1680-1686. https://doi.org/10.1212/WNL.0b013e3181e07d14
  7. Odaka M, Yuki N, Hirata K. Patients with chronic inflammatory demyelinating polyneuropathy initially diagnosed as Guillain-Barre syndrome. J Neurol 2003;250:913-916. https://doi.org/10.1007/s00415-003-1096-y
  8. Xie JG, Cai Y, Davis LE. Guillain-Barre syndrome and hepatitis A: lack of association during a major epidemic. Ann Neurol 1988;24:697-698.
  9. Comi C, Osio M, Ferretti M, Mesturini R, Cappellano G, Chiocchetti A, et al. Defective Fas-mediated T-cell apoptosis predicts acute onset CIDP. J Peripher Nerv Syst 2009;14:101-106. https://doi.org/10.1111/j.1529-8027.2009.00219.x
  10. Tackenberg B, Jelcic I, Baerenwaldt A, Oertel WH, Sommer N, Nimmerjahn F, et al. Impaired inhibitory Fcgamma receptor IIB expression on B cells in chronic inflammatory demyelinating polyneuropathy. Proc Natl Acad Sci U S A 2009;106:4788-4792. https://doi.org/10.1073/pnas.0807319106